Nuzenio

Alzamend Neuro

Alzamend Neuro news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 12:19:48 GMTAlzamend Neuro lands $25M convertible deal from Ault Lending for Alzheimer's trials - Dealroom
Tue, 04 Aug 2026 12:00:00 GMTAlzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending - PR Newswire
Tue, 04 Aug 2026 07:00:00 GMTAlzamend Neuro raises $7.5 million in unregistered sale of Series D convertible preferred stock to Ault Lending - Bitget
Mon, 03 Aug 2026 20:33:00 GMTAlzamend Neuro Secures Up to $25 Million Series D Preferred Financing; $7.5 Million Funded - TradingView
Mon, 03 Aug 2026 20:33:00 GMTAlzamend Neuro Received Notice of Noncompliance - TradingView
Mon, 27 Jul 2026 07:00:00 GMTAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Alzamend Neuro.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.